Back
Emergent BioSolutions Vs. Geovax Labs Industry Stock Comparison
Sell
44
EBS
Emergent BioSolutions
Last Price:
9.48
Seasonality Move:
13.84%
Sell
38
GOVX
Geovax Labs
Last Price:
2.94
Seasonality Move:
-1.66%
Sell
44
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $9.40. The Score for EBS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- EBS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Geovax Labs (GOVX)
is a Sell
Is Geovax Labs a Buy, Sell or Hold?
- The current Geovax Labs [GOVX] share price is $2.70. The Score for GOVX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- GOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $9.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EBS is experiencing slight buying pressure.
GOVX Stock Price Chart
What is Geovax Labs's stock price today?
-
The Geovax Labs share price today is $2.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOVX is experiencing slight buying pressure.
EBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 50.73 | Buy |
| Chaikin Money Flow: | 255537 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.49 - 10.47) | Sell |
| Bollinger Bands (100): | (7.36 - 11.04) | Buy |
GOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 54.52 | Buy |
| Chaikin Money Flow: | 282825 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.87 - 2.73) | Buy |
| Bollinger Bands (100): | (1.6 - 4.28) | Sell |
EBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.13 | Buy |
| 20-day SMA: | 9.52 | Sell |
| 50-day SMA: | 8.72 | Buy |
| 200-day SMA: | 6.43 | Buy |
| 8-day EMA: | 9.16 | Buy |
| 20-day EMA: | 9.33 | Buy |
| 50-day EMA: | 9.06 | Buy |
| 200-day EMA: | 7.46 | Buy |
GOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.78 | Sell |
| 20-day SMA: | 2.33 | Buy |
| 50-day SMA: | 2.35 | Buy |
| 200-day SMA: | 2.44 | Buy |
| 8-day EMA: | 2.67 | Buy |
| 20-day EMA: | 2.49 | Buy |
| 50-day EMA: | 2.54 | Buy |
| 200-day EMA: | 9.36 | Sell |
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.87 per share, and an increase next year of $3.99 per share.
Geovax Labs Earnings Growth & GOVX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Emergent BioSolutions Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Geovax Labs Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||